Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes
Agreed
But the reset could take it back to double or triple from here
Me too
Buying here
I originally bought this around $15 years ago and sold it when it crossed $100
Here we go again
I meant $1.90’s
Sorry
It will come back up.
People that sold have been waiting for mid- to low $2.90’s to jump back in.
Smart shorts should cover in low $2.90’s driving it back up quickly.
IMHO
NVAX
By Tina Reed
Staff Reporter, Washington Business Journal
Jan 23, 2018, 3:07pm EST
Updated Jan 23, 2018, 4:12pm
Gaithersburg vaccine maker Novavax Inc. (NASDAQ: NVAX) saw its share price spike for the second time this month, increasing 11 percent from $2.01 at Monday's opening bell to $2.23 at the close of Tuesday trading.
The price jump came just a few weeks after the company experienced a 50 percent jump that followed a company report about its clinical trials. That prompted an "uber-bullish" rating from an B. Riley FBR Inc. analyst, raising Novavax's 12-month price target from $2.25 to $10.
NVAX
Setting up new floor price in the $2.06 range.
Should churn here for a bit getting ready for the next leg up.
Looks like a great opportunity for shorts to cover before it takes off again ??
JMHO
NVAX
Novavax is enjoying a stock surge that raised its share price 11 percent so far this week.
By Tina Reed
Staff Reporter, Washington Business Journal
Jan 23, 2018, 3:07pm EST
Gaithersburg vaccine maker Novavax Inc. (NASDAQ: NVAX) saw its share price spike for the second time this month, increasing 11 percent from $2.01 at Monday's opening bell to $2.23 at the close of Tuesday trading.
The price jump came just a few weeks after the company experienced a 50 percent jump that followed a company report about its clinical trials. That prompted an "uber-bullish" rating from an B. Riley FBR Inc. analyst, raising Novavax's 12-month price target from $2.25 to $10.
BLRX
BioLineRx Presents Preclinical Data at ASCO-SITC Showing BL-8040 Prolongs Survival by Mediating Tumor Infiltration of Antigen-Specific T-cell
https://finance.yahoo.com/news/biolinerx-presents-preclinical-data-asco-130000549.html
NVAX pre-market volume looking good
NVAX
Another great day here today
NVAX pulled back a bit today from yesterday’s 60% run
Very easy double in PPS IMHO from this level
NVAX really took off for me today
Up 47% today
Good buying opportunity right now at $5.59 level
I don’t see this going sub-5’s
$CUE closed at $14.99 today
it’s just starting to churn !
Hello Kei,
Happy New Year!
$CUE is set to present company overview today in San Francisco at 11:15 local time.
Just did their IPO
Currently at $14.60
Take a look at it.
CUE
Just did their IPO
Presenting tomorrow in SF
Take a look
I’m in
Hoping for a nice run here next 4 quarters.
Conditions seem right to me for run up here.
Happy 2018 Longs
There is really no volume here at all.
I? think it’s mostly manipulation by whoever holds the strings on this elaborate play.
I? can’t think of any good reason to not have press releases .
We deserve better from this company .
CRHM
Keep an eye on this one.
Over-corrected recently and back up from recent low of $2.15
IMHO this is headed for an easy double from current price on solid book of business.
CRHM
Consolidating around $2.40 for a few days.
Solid financials on this one.
PT over $5
CRHM
Up over 13% today.
Headed over $5 IMHO
Remember CRHM?
I gave you a head's up in the .60 range. It shot up to over $9.
Now, huge pullback to $2.50 just this week on sound financials.
I just bought a ton of this again !
PT for me over $5
Good luck. JMHO
I bought more again this AM
I have s nice position now at a reasonable price.
I'm happy to hold this for now.
Yep
I was agreeing with him actually!!
Good to hear from you again!
Actually
The positives far outweigh the negatives here.
The recurrence rate for posterior segment uveitis was halved.
The cost was higher IOP that required medication (no surgery).
You will see this getting approved in both Europe and the US.
This is a pullback fueled by ignorance.
I'm buying more here!
Any news, comments, thoughts here?
I'm in at $2.28
Positioned for a nice run!
Actually over $6,000 bailed at .155 it only took $36 (200 shares at .18) to bring it back up.
I don't think it would take much to get us back up to $.80
Maybe $100,000-$150,000.
If we just kept buying up the asks .
IMG_2921.PNG
Well over 25,000 shares sold at $.155
They have gone completely off the radar and radio silence !
Reminds me of an old submarine movie
Thanks !
Other than blind faith, what makes you think they will ultimately succeed?
I'm concerned about a company with so little regard for it's publicly traded share price.
I don't agree at all.
Most oil sector companies have bounced some.
This thing does not have a heart beat
Looks like a great buying opportunity to me.
JMHO
I agree but I'm looking at longer term here.
I just picked up a nice block at $5.15
I'm doing the sane thing and buying up another block down here.
CHK beats the street and should bounce.